Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code AGR

16. Specific lobbying issues

Livestock Cloning/Product Labeling
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Discussions with EU on Animal Cloning

Biomass Crop Assistance Program (BCAP)
2007 Farm Bill Implementation

Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings

EPA Regulations on Agricultural Biotechnology
FIFRA Section 7 Regulations
Reauthorization and Implementation of Pesticide Registration Improvement Act

Foreign Agriculture Biotechnology Laws and Regulations
Discussions with EU on Animal Cloning
EU Biotechnology Bilateral Discussions
Japan Biotechnology Regulations
Low-Level Presence Foreign Government Policies
Turkish Biotechnology Regulations
Vietnam Biotechnology Regulations

Funding for the USDA
Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2011

Genetically Engineered (GE) Animals
FDA Approval
Labeling

Global Food Security Initiative
Funding
Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2011

U.S. Policy on Sustainable Agriculture Standard
American National Standards Institute (ANSI) Sustainable Agriculture Standards

USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems

World Trade Organization on EU Biotech Approvals
EU Biotechnology Negotiations

Export Registrations for Products With Expired Patents

Fish and Wildlife Service Policy on Planting of Biotech Crops

U.S. Policy on International Science-Based Regulations

Labeling of Genetically Engineered Crops
U.S. Government Policy
U.S. Government Position in Codex Alimentarius Commission

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), State - Dept of (DOS), Commerce - Dept of (DOC), U.S. Fish & Wildlife Service (USFWS), U.S. Trade Representative (USTR), U.S. Agency for International Development (USAID),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ANI

16. Specific lobbying issues

Genetically Engineered (GE) Animals
FDA Approval
Labeling

Livestock Cloning/Product Labeling
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Discussions with EU on Animal Cloning

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), U.S. Trade Representative (USTR),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Funding for the Food and Drug Administration (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall
Foundation, Center for Veterinary Medicine, Scientific Infrastructure)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011 Cont...
Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Service (APHIS), Animal Care & Veterinary
Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research
Service, Biofuels, Foreign Agricultural Service)
Livestock Cloning/Product Labeling
Funding for Biofuels and Bio-based Products

Budget of the United States for FY 2011
Funding for Biofuels and Bio-based Products

Department of Homeland Security Appropriations Act for FY 2011
Drug Importation

Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2011
Funding for Biotechnology Research and Development Programs at the Agency for International Development and
Department of State
Funding for Global Food Security Initiative
Funding for the Bureau of Economic, Energy, and Business Affairs (EEB) at the Department of State

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
Funding for National Institutes of Health
Cures Acceleration Network
Funding for Bioterrorism and Emergency Preparedness
Funding for Pandemic Influenza Preparedness
Funding for Biomedical Advanced Research and Development Authority (BARDA)
Funding for Centers for Disease Control and Prevention Vaccine Programs
Funding for Strategic National Stockpile
Drug Importation

Energy and Water Development and Related Agencies Appropriations Act for FY 2011
Funding for Biofuels and Bio-based Products
Funding for Biorefineries
Funding for Reverse Auction Loan Program under Section 942 of the Energy Policy Act of 2005
Title XVII Loan Guarantee Program

H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
Funding for Bioterrorism and Emergency Preparedness
Funding for Pandemic Influenza Preparedness
Average Manufacturer Price Calculations
Generic Drug Patent Settlements
Funding for Biofuels and Bio-based Products

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Natl Security Council (NSC), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CAW

16. Specific lobbying issues

Climate Change Benefits of Biofuels and Bio-based Products
H.R. 2454: American Clean Energy and Security Act of 2009
Bio-based Product Tax Credit
Senate Climate Change Discussion Draft (Sen. Kerry, Graham & Lieberman)
IP Rights for Environmental Technologies
U.S. Government Position for U.N. Convention on Climate Change Negotiations

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, State - Dept of (DOS), Agriculture - Dept of (USDA), White House Office, Commerce - Dept of (DOC), Patent & Trademark Office (PTO)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

Patent Reform
H.R. 1260: The Patent Reform Act of 2009
S. 515. The Patent Reform Act of 2009
S.610: The Patent Reform Act of 2009
Patent Reform Cont...
Proposed Ban on Tax Preparation Patents: Senate Finance Committee Draft

Genetic Resource Patent Disclosure Requirements
Convention on Biological Diversity
World Intellectual Property Organization

DNA Patenting and Licensing
Bayh-Dole Act/Tech Transfer
Genomic Research and Accessibility Act Discussion Draft (Rep. Becerra)
Amicus Matters
Possible Legislation by Rep. Wasserman Schultz

IP Rights for Environmental Technologies
U.S. Government Position for U.N. Convention on Climate Change Negotiations

Generic Drug Patent Settlements
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
H.R. 4213: American Jobs & Closing Tax Loopholes Act
S.4322: Preserve Access to Affordable Generics Act

PTO Administrative Reforms

World Trade Organization Special 301 Submissions

Bayh-Dole Act/Tech Transfer
Commercialization of Federally Funded Research Initiative

Intellectual Property International Enforcement

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, State - Dept of (DOS), U.S. Trade Representative (USTR), Patent & Trademark Office (PTO), Commerce - Dept of (DOC), Natl Institutes of Health (NIH), White House Office, Agriculture - Dept of (USDA), Natl Economic Council (NEC),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CSP

16. Specific lobbying issues

Genetically Engineered (GE) Animals
FDA Approval
Labeling

Drug Importation
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
Department of Homeland Security Appropriations Act for FY 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011

Funding for the Food and Drug Administration
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011

Livestock Cloning/Product Labeling
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Discussions with EU on Animal Cloning

USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems

Generic Drug Patent Settlements
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
H.R. 4213: American Jobs & Closing Tax Loopholes Act
S.4322: Preserve Access to Affordable Generics Act

Labeling of Genetically Engineered Crops
U.S. Government Policy
U.S. Government Position in Codex Alimentarius Commission

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), U.S. Trade Representative (USTR),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ENG

16. Specific lobbying issues

Renewable Fuels Standard
EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements
Implementation of Energy Independence and Security Act of 2007
Regulatory Oversight
Algae-based Renewable Fuel/Carbon Capture and Conversion
Biofuels Production Tax Credit Modification for Algae-based Biofuels
S.1250: Algae-based Renewable Fuel Promotion Act of 2009
H.R. 5142 Grow Renewable Energy Economy Now- Jumpstart Other Biofuels Act of 2010
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2009

Bio-based Products
Tax Credits
Expansion of DOE and USDA Loan Guarantee Programs
Funding
Budget of the United States for FY 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
Next Generation Incentives
Farm Bill Reauthorization

Biofuels
Biofuels Production Tax Credit Extension
H.R. 5142 Grow Renewable Energy Economy Now- Jumpstart Other Biofuels Act of 2010
DOE Loan Guarantees and Grants under The Energy Policy Act of 2005 (Implementation and Funding)
Economic Growth Impact/Potential of Advanced Biofuels
Funding
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Budget of the United States for FY 2011
Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
Next Generation Incentives
Farm Bill Reauthorization
Investment Tax Credit Option
H.R. 5142: Grow Renewable Energy Economy Now- Jumpstart Other Biofuels Act of 2010

Biorefineries
Funding for Reverse Auction Loan Program Under Section 942 of the Energy Policy Act of 2005
Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 5142: Grow Renewable Energy Economy Now- Jumpstart Other Biofuels Act of 2010

Climate Change Benefits of Biofuels and Bio-based Products
Bio-based Product Tax Credits
H.R. 2454: American Clean Energy and Security Act of 2009
Senate Climate Change Discussion Draft ( Sen. Kerry, Graham & Lieberman)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), White House Office, Energy - Dept of

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code FOO

16. Specific lobbying issues

Genetically Engineered (GE) Animals
FDA Approval
Labeling
Livestock Cloning/Product Labeling
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Discussions with EU on Animal Cloning

Global Food Security Initiative
Funding
Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2011

Labeling of Genetically Engineered Crops
U.S. Government Policy
U.S. Government Position in Codex Alimentarius Commission

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), U.S. Trade Representative (USTR), State - Dept of (DOS), U.S. Agency for International Development (USAID),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code FUE

16. Specific lobbying issues

Renewable Fuels Standard
EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements
Implementation of Energy Independence and Security Act of 2007
Regulatory Oversight
Algae-based Renewable Fuel/Carbon Capture and Conversion
Biofuels Production Tax Credit Modification for Algae-based Biofuels
S.1250: Algae-based Renewable Fuel Promotion Act of 2009
H.R. 5142 Grow Renewable Energy Economy Now- Jumpstart Other Biofuels Act of 2010
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2009

Bio-based Products
Tax Credits
Expansion of DOE and USDA Loan Guarantee Programs
Funding
Budget of the United States for FY 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
Next Generation Incentives
Farm Bill Reauthorization

Biofuels
Biofuels Production Tax Credit Extension
H.R. 5142 Grow Renewable Energy Economy Now- Jumpstart Other Biofuels Act of 2010
DOE Loan Guarantees and Grants under The Energy Policy Act of 2005 (Implementation and Funding)
Economic Growth Impact/Potential of Advanced Biofuels
Funding
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Budget of the United States for FY 2011
Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
Next Generation Incentives
Farm Bill Reauthorization
Investment Tax Credit Option
H.R. 5142: Grow Renewable Energy Economy Now- Jumpstart Other Biofuels Act of 2010

Biorefineries
Funding for Reverse Auction Loan Program Under Section 942 of the Energy Policy Act of 2005
Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 5142: Grow Renewable Energy Economy Now- Jumpstart Other Biofuels Act of 2010

Climate Change Benefits of Biofuels and Bio-based Products
Bio-based Product Tax Credits
H.R. 2454: American Clean Energy and Security Act of 2009
Senate Climate Change Discussion Draft ( Sen. Kerry, Graham & Lieberman)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Environmental Protection Agency (EPA), Agriculture - Dept of (USDA), Energy - Dept of, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Alliance for Healthcare Competitiveness

Biosimilars
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Comparative Effectiveness Program Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Nomination of Board Members for the Patient-Centered Outcomes Research Institute

Cures Acceleration Network
Funding
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for
FY 2011
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Drug Importation
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Department of Homeland Security Appropriations Act for FY 2011
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011

Expansion of 340B Drug Pricing Program
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010

Funding for Biomedical Advanced Research & Development Authority (BARDA)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011

Funding for Bioterrorism and Emergency Preparedness
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010

Funding for National Institutes of Health
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011

Funding for Pandemic Influenza Preparedness
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010

Funding for Strategic National Stockpile
Department of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Funding for the Food and Drug Administration
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011

Medicaid Rebates
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Medicare Prescription Drug Coverage
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Stem Cell Research

Therapeutic Discovery Project Tax Credit
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act



Average Manufacturer Price Calculations
H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010

Biodefense Research, Development and Procurement
S.1649/H.R 5498: Weapons of Mass Destruction Prevention and Preparedness Act

Human Drug Review Program
Prescription Drug User Fee Act (PDUFA) Reauthorization
Critical Path Initiative

Diagnostics and Personalized Medicine Regulation and Oversight
Draft Legislation

Funding for Centers for Disease Control and Prevention Vaccine Programs
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011

Expanded Access to Experimental Products
FDA Rules

Vaccine Access/Financing
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act: GAO Study

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Treasury - Dept of, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Government Accountability Office (GAO), White House Office, Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), Natl Economic Council (NEC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HOM

16. Specific lobbying issues

Funding for Biomedical Advanced Research & Development Authority (BARDA)
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011


Funding for Bioterrorism and Emergency Preparedness
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010

Funding for Strategic National Stockpile
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Biodefense Research, Development and Procurement
S.1649/H.R 5498: Weapons of Mass Destruction Prevention and Preparedness Act

Funding for Pandemic Influenza Preparedness
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Security Council (NSC), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

Biodefense Research, Development and Procurement
S.1649/H.R 5498: Weapons of Mass Destruction Prevention and Preparedness Act

Comparative Effectiveness Program Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Nomination of Board Members for the Patient-Centered Outcomes Research Institute

Cures Acceleration Network
Funding
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for
FY 2011
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Funding for Biomedical Advanced Research & Development Authority (BARDA)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011

Funding for Bioterrorism and Emergency Preparedness
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010

Funding for National Institutes of Health
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011

Funding for Pandemic Influenza Preparedness
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010

Stem Cell Research

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Government Accountability Office (GAO), White House Office, Natl Security Council (NSC),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Medicaid Rebates
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Medicare Prescription Drug Coverage
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Average Manufacturer Price Calculations
H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SCI

16. Specific lobbying issues

Small Business Innovation and Research (SBIR) Program Reauthorization
H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009

Stem Cell Research
Research & Development Tax Credit Extension
HR 4213: American Jobs and Closing Tax Loopholes Act of 2010

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SMB

16. Specific lobbying issues

Small Business Innovation and Research (SBIR) Program Reauthorization
H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009

Modifications to Internal Revenue Code Section 1202 for Qualified Small Business Stock Incentive
H.R. 4173: Wall Street Reform and Consumer Protection Act of 2009

Sarbanes Oxley Section 404 (b) Exemption
H.R. 4173: Wall Street Reform and Consumer Protection Act of 2009
Senate Financial Regulatory Reform Discussion Draft

Therapeutic Discovery Project Tax Credit
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Small Business Early-Stage Investment
H.R. 5297: Small Business Lending Fund Act of 2010

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA), Treasury - Dept of, Securities & Exchange Commission (SEC), Food & Drug Administration (FDA), Office of Management & Budget (OMB), Natl Institutes of Health (NIH)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Therapeutic Discovery Project Tax Credit
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act


Bio-based Products
Tax Credits

Biofuels Production Tax Credit Extension
H.R. 5142: Grow Renewable Energy Economy Now- Jumpstart Other Biofuels Act of 2010

Biofuels Production Tax Credit Modification for Algae-based Biofuels
H.R. 5142: Grow Renewable Energy Economy Now- Jumpstart Other Biofuels Act of 2010
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2009
S.1250: Algae-based Renewable Fuel Promotion Act of 2009

Biofuels Investment Tax Credit Option
H.R. 5142: Grow Renewable Energy Economy Now- Jumpstart Other Biofuels Act of 2010

Election of R&D/AMT Tax Credits in Lieu of Bonus Depreciation
Senate Substitute to H.R. 5297: Small Business Lending Fund Act of 2010

Modifications to Internal Revenue Code Section 1202 for Qualified Small Business Stock Incentive
H.R. 4173: Wall Street Reform and Consumer Protection Act of 2009
Senate Financial Regulatory Reform Discussion Draft

Research & Development Tax Credit Extension
HR 4213: American Jobs and Closing Tax Loopholes Act of 2010

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of, Office of Management & Budget (OMB), Food & Drug Administration (FDA), Securities & Exchange Commission (SEC), Natl Institutes of Health (NIH)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TRD

16. Specific lobbying issues

Alliance for Healthcare Competitiveness

Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings
Drug Importation
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Department of Homeland Security Appropriations Act for FY 2011
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011

Foreign Agriculture Biotechnology Laws and Regulations
Discussions with EU on Animal Cloning
EU Biotechnology Bilateral Discussions
Japan Biotechnology Regulations
Low-Level Presence Foreign Government Policies
Turkish Biotechnology Regulations
Vietnam Biotechnology Regulations

Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning

World Trade Organization on EU Biotech Approvals
EU Biotechnology Negotiations

Export Registrations for Products With Expired Patents

U.S. Policy on International Science-Based Regulations

Intellectual Property International Enforcement

Genetic Resource Patent Disclosure Requirements
Convention on Biological Diversity
World Intellectual Property Organization

World Trade Organization Special 301 Submissions

Labeling of Genetically Engineered Crops
U.S. Government Policy
U.S. Government Position in Codex Alimentarius Commission

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), State - Dept of (DOS), U.S. Trade Representative (USTR), Commerce - Dept of (DOC), Patent & Trademark Office (PTO), Food & Drug Administration (FDA), Natl Economic Council (NEC), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

Comparative Effectiveness Program Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Nomination of Board Members for the Patient-Centered Outcomes Research Institute
Medicaid Rebates
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Medicare Prescription Drug Coverage
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Government Accountability Office (GAO), White House Office, Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TOR

16. Specific lobbying issues

Class Action Fairness Act Amendments
H.R. 5503: Securing Protections for the Injured From Limitations on Liability Act

Ban on Protective Orders
H.R. 5503: Securing Protections for the Injured From Limitations on Liability Act

Appointment of Registered Agents
H.R. 4678: Foreign Manufacturers Legal Accountability Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization